Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Behavioral Neurology & Neuropsychiatry
126 providers 8,159 records General Payments
General Payments — all loaded program years
- Category: General Payments
- Providers: 126
- Record count: 8,159
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
Counts cover General Payments records for physicians and non-physician practitioners whose CMS-published primary specialty is shown above. Payments to teaching hospitals are not included, and Research and Ownership/Investment are separate datasets never included here.
Coverage: program years 2019–2025, General Payments only. Provider identity and specialty are taken from the CMS Covered Recipient Profile Supplement and shown with formatting only; grouping is a display aid, not a determination of identity.
Providers (126)
Sorted by name; identical names by identifier.
By program year
Each links to what was reported on this specialty in that program year.
Every company reporting on this specialty (169)
Sorted by name; identical names by identifier. Each links to what that company reported on this specialty.
- Sunovion Pharmaceuticals Inc.
- Supernus Pharmaceuticals, Inc.
- Takeda Pharmaceuticals U.S.A., Inc.
- Tempus AI, Inc
- Teva Pharmaceuticals USA, Inc.
- TG THERAPEUTICS, INC.
- TONIX PHARMACEUTICALS, INC.
- TREACE MEDICAL CONCEPTS, INC.
- Tris Pharma Inc
- UCB, Inc.
- UPSHER-SMITH LABORATORIES LLC
- Urgo Medical North America, LLC
- USWM, LLC
- Validus Pharmaceuticals LLC
- Vanda Pharmaceuticals Inc.
- Vertical Pharmaceuticals, LLC
- W. L. Gore & Associates, Inc.
- Xeris Pharmaceuticals, Inc.
- Zyla Life Sciences